Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial-Reference-Cited by-同舟云学术

Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial

Published:2017-12 Issue:1 Volume:18 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Martin Naomi H., ,Ibrahim Fowzia,Tom Brian,Galloway James,Wailoo Allan,Tosh Jonathan,Lempp Heidi,Prothero Louise,Georgopoulou Sofia,Sturt Jackie,Scott David L.

Funder

Programme Grants for Applied Research

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-017-2330-8.pdf

Reference63 articles.

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–108.

2. Pugner KM, Scott DL, Holmes JW, Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum. 2000;29:305–20.

3. Scott DL, Steer S. The course of established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21:943–67.